In the highly regulated environment of clinical research, maintaining objective oversight is critical to ensuring data integrity, patient safety, and regulatory approval. Headquartered in the United States, Protheragen serves as a holistic partner for clinical research and regulatory operations.
Internal quality control is often insufficient to detect systemic blind spots within complex clinical landscapes. To support organizational compliance, Protheragen provides a comprehensive suite of quality assurance & audits services. As an independent entity, we provide objective evaluations of your clinical trial processes, documentation, and partner facilities to identify potential risks before they escalate into regulatory compliance issues. Whether you are preparing for a regulatory inspection or seeking routine quality assurance oversight, our seasoned professionals possess the deep industry knowledge required to evaluate your programs with academic and technical rigor.
Protheragen provides a structured, independent framework covering all key areas of clinical development. Each service is executed by qualified professionals following a methodology aligned with ICH GCP principles and applicable international regulatory standards.
We provide a completely neutral perspective, free from internal organizational biases, to evaluate trial conduct strictly on factual evidence and regulatory standards.
Robust compliance relies fundamentally on well-trained personnel. Our curriculum bridges theoretical knowledge and practical execution:
Pre-Inspection Preparation and Facilitation of Health Authority Inspections
Health authority inspections determine the validity of clinical data and the ultimate approvability of a therapeutic candidate. By simulating the inspection environment, we help mitigate regulatory risks and reduce the likelihood of critical findings.
Quality assurance and audit activities play an essential role in clinical trials by providing independent evaluation of processes and documentation. They help ensure that trial conduct can be demonstrated through reliable records and that systems are capable of supporting regulatory review.
Regular audits and quality assessments allow organizations to identify gaps early, maintain consistency across studies, and prepare for regulatory inspections. By integrating quality assurance into routine operations, organizations can support both compliance and operational efficiency.
If your organization is seeking support in quality assurance, audit activities, or inspection readiness, Protheragen is available to assist. We work collaboratively with clients to understand their processes and provide structured, practical support aligned with their clinical trial needs.
Please contact us to discuss your specific requirements and explore how our quality assurance & audits services can support your quality objectives.
1. What is a third-party clinical trial audit?
A third-party clinical trial audit is an independent, systematic examination of trial-related activities and documents conducted by an organization not directly involved in the study. It evaluates compliance with the protocol, GCP, standard operating procedures, and applicable regulatory requirements.
2. Why should I choose an independent third-party auditor over conducting internal assessments?
Third-party auditors provide an objective perspective that is free from internal influences or operational familiarity. This independence strengthens the credibility of findings and demonstrates to partners and regulators a genuine commitment to impartial quality oversight.
3. What happens if a mock inspection reveals critical compliance gaps?
Identifying hidden gaps is the precise purpose of a mock inspection. If critical issues are found, we collaborate with your team to perform root cause analyses, develop robust CAPA plans, and storyboard the remediation process so you can present a transparent narrative to actual inspectors.
4. Are audit findings and client data kept confidential?
Yes. All Protheragen QA and audit engagements are governed by strict confidentiality agreements. Audit reports and findings are shared only with authorized client representatives, and data is handled in accordance with applicable data protection requirements.